ArticleTranslational oncology2019

Preclinical In Vitro and In Vivo Evidence of an Antitumor Effect of CX-4945, a Casein Kinase II Inhibitor, in Cholangiocarcinoma.

Kais Zakharia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.